Trump Targets Hospital Abuse of Drug Discounts

The Trump administration is moving forward with a new approach to the 340B drug discount program that will require participating drug manufacturers to provide discounts through rebates only after claims are submitted and verified.The Health Resources and Services Administration (HRSA) announced a revised 340B Rebate Model Pilot Program that will apply to certain drugs beginning in 2026. The announcement moves the rebate model from a proposed reform toward implementation as the administration see